The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Neil Wood MBE joins Board of PVG plc

29 Aug 2018 07:00

RNS Number : 0554Z
Premier Veterinary Group PLC
29 August 2018
 

PREMIER VETERINARY GROUP PLC

 

("PVG", the "Company" or the "Group")

 

Neil Wood MBE joins Board of PVG plc as independent Non-Executive Director

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

 

London, UK, 29 August 2018 (LSE: PVG): PVG is pleased to announce that Neil Wood MBE has accepted the appointment of independent Non-Executive Director of PVG with effect from 3 September 2018. He will also takeover Chairmanship of the Audit Committee and be a member of the Remuneration and Nomination Committee. 

 

Neil, a Fellow of the Institute of Chartered Accountants, has over 30 years' experience advising boards across a variety of industries. Neil began his career with Arthur Andersen, became a partner in 2000 and spent 17 years as an audit partner and then management consulting partner in Deloitte LLP serving clients across the globe. Neil was part of London's bid for the 2012 Olympics as its Chief Financial Officer and received the award of an MBE in recognition of his contribution in securing the Olympics for London. He went on to be appointed as Chief Financial Officer and Executive Board Member of the London Organising Committee of the Olympic and Paralympic Games ("LOCOG").

Following the dissolution of LOCOG, Neil was CFO of the British Business Bank, preparing the bank for its launch later that year and has advised clients across the World on bidding for and delivering major complex programmes including the Tokyo 2020, Paris 2024 and Los Angeles 2028 Olympic Games and the Lima 2019 Pan American Games.

 

Since retiring from Deloitte in 2017 Neil has established his own consulting business advising clients on the governance and delivery of complex programmes. He also holds a number of charitable board positions where he sits on or chairs the Risk and Audit Committee.

 

Graham Dick, Non-Executive Chairman and Director of PVG, added:

"I could not be more pleased that our business can attract someone with Neil's track record. He joins us at a very exciting stage in our development and with his international experience and expertise in finance and corporate strategy he will no doubt make a significant contribution in furthering our international growth ambitions."

 

The Board will continue to consider the balance and composition of the Board and, in particular, whether an additional independent non-executive director is required given the current size of the business. In order to support decision making, Rajan Uppal will continue to be a member of the Audit, Remuneration and Nomination Committees as advised in the Company's 2017 Annual Report.

 

There are no further disclosures required under LR 9.6.13.

 

 

-Ends-

 

For further information, please contact:

 

Premier Veterinary Group plc 

Tel: +44 (0)117 970 4130

Dominic Tonner, Chief Executive Officer 

Will Evans, Chief Financial Officer 

 

 

Note to Editors:

 

PVG's services to third party veterinary practices, through its wholly owned subsidiary, Premier Vet Alliance Limited ("PVA"), include the administration and support of a preventative healthcare programme for pets branded "Premier Pet Care Plan" ("PPCP"). In the US, where veterinary practices are known as veterinary hospitals, PPCP is marketed through the Company's wholly owned subsidiary, Premier Vet Alliance (US) Limited.

 

PPCP is a structured, preventative healthcare programme for cats, dogs and rabbits and is available only through veterinary practices/hospitals. The programme is seen as a way of providing gold standard care for pets at an affordable price for the client, by way of fixed monthly payments.

 

PPCP uses a clinical approach to prevention, as this is the most effective method of ensuring illnesses are diagnosed more quickly and not given a chance to advance. What truly sets PPCP apart is its unique approach of offering an end-to-end solution and support to the practice/hospital, which has been proven to work extremely well. PVA works alongside practices/hospitals to create a tailor-made, cost-effective service for clients, one that delivers excellent care to their patients and significantly improves practice/hospital performance.

 

For further details:

www.premiervetgroup.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOALLFSRTIITFIT
Date   Source Headline
2nd Jun 20154:55 pmRNSChange of Auditor
29th May 20157:00 amRNSHalf Yearly Report
7th May 20153:42 pmRNSChange of Registered Office
29th Apr 20157:01 amRNSTrading Statement
29th Apr 20157:00 amRNSFinal Results
13th Mar 201511:22 amRNSHolding(s) in Company
9th Mar 20157:00 amRNSRenamed Premier Veterinary Group
3rd Mar 201512:33 pmRNSHolding(s) in Company
3rd Mar 20159:48 amRNSHolding(s) in Company
2nd Mar 20152:36 pmRNSHolding(s) in Company
2nd Mar 201510:55 amRNSHolding(s) in Company
2nd Mar 201510:42 amRNSHolding(s) in Company
27th Feb 20154:35 pmRNSPrice Monitoring Extension
27th Feb 20154:07 pmRNSBoard Changes and Directors' Dealings
27th Feb 20158:00 amRNSCancellation
27th Feb 20157:00 amRNSAdmission to the Official List
26th Feb 20154:00 pmRNSCancellation and Publication of Prospectus
5th Feb 20154:22 pmRNSAcquisition completed
28th Jan 20159:29 amRNSSale and Purchase Agreement Signed
15th Jan 20157:00 amRNSTransfer of listing category on the Official List
4th Dec 201411:17 amRNSBlocklisting Interim Review
21st Nov 20145:48 pmRNSPosting of Circular
1st Aug 20147:00 amRNSHalf Yearly Report and Change of Registered Office
1st Jul 20147:00 amRNSResults of AGM and Board Changes
3rd Jun 20147:00 amRNSBlocklisting Interim Review
13th May 20147:00 amRNSInterim Management Statement
30th Apr 20147:00 amRNSFinal Results
28th Mar 20147:45 amRNSSuspension - Ark Therapeutics Group Plc
28th Mar 20147:32 amRNSSigned Heads of Terms and Suspension of Trading
25th Mar 201412:48 pmRNSHolding(s) in Company
4th Mar 201412:22 pmRNSHolding(s) in Company
21st Feb 20144:40 pmRNSSecond Price Monitoring Extn
21st Feb 20144:35 pmRNSPrice Monitoring Extension
20th Feb 201410:44 amRNSHolding(s) in Company
20th Feb 201410:39 amRNSHolding(s) in Company
20th Feb 201410:38 amRNSHolding(s) in Company
6th Dec 20135:46 pmRNSBlocklisting Interim Review
6th Nov 20137:00 amRNSInterim Management Statement
8th Oct 201311:27 amRNSHolding(s) in Company
7th Oct 20134:35 pmRNSPrice Monitoring Extension
7th Oct 20133:21 pmRNSHolding(s) in Company
27th Sep 201311:46 amRNSHolding(s) in Company
26th Sep 20133:26 pmRNSHolding(s) in Company
24th Sep 201311:02 amRNSHolding(s) in Company
20th Sep 201311:47 amRNSHolding(s) in Company
18th Sep 20134:40 pmRNSSecond Price Monitoring Extn
18th Sep 20134:35 pmRNSPrice Monitoring Extension
17th Sep 201310:00 amRNSHolding(s) in Company
13th Sep 201311:40 amRNSHolding(s) in Company
10th Sep 201310:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.